Renal Cell Carcinoma News

• Injectable Gel Delivers Immune Cells Directly to Cancer Tumors Stanford University engineers created a new delivery method that may enhance CAR T-cell therapy by targeting solid tumors such as breast cancer.
  Medscape Medical News, April 14, 2022
• More Leisure Activity Reduces Risk of Obesity-related Cancers This risk reduction held regardless of a person's weight but appeared most pronounced for those with low-to-normal BMIs.
  Medscape Medical News, April 13, 2022
• Vitiligo From Checkpoint Inhibitors Not Limited to Melanoma Vitiligo can occur in any type of cancer, according to a new study published as a preprint and that has not yet peer reviewed.
  First Look, February 15, 2022
• Skin Toxicity May Predict Immune Checkpoint Inhibitor Response In patients with cancer, cutaneous immune-related adverse events were strongly associated with response to immune checkpoint inhibitors and survival in a retrospective study.
  Reuters Health Information, January 20, 2022
• SABR With Pembrolizumab Benefits Oligometastatic Kidney Cancer The combination of stereotactic ablative body radiotherapy and a short-course of pembrolizumab is well tolerated and provides excellent local control of oligometastatic renal-cell carcinoma.
  Reuters Health Information, December 29, 2021
• Immunotherapy Combo Fails to Improve OS in Advanced Kidney Cancer In previously untreated metastatic renal-cell cancer, upfront treatment with atezolizumab plus bevacizumab did not improve overall survival compared to standard treatment with sunitinib in the IMmotion151 study.
  Reuters Health Information, December 27, 2021
• City of Hope Spinoff Offers Remote Second Opinions An early study showed that significant changes to treatment plans were recommended for more than one quarter of patients with lung cancer.
  Medscape Medical News, December 23, 2021
• Using Renal Scoring Criteria May Spare Children's Kidneys Applying renal scoring criteria to children with kidney masses may help identify some who can be offered nephron-sparing surgery, instead of a radical nephrectomy, which is the standard of care.
  Medscape Medical News, December 21, 2021
• New Trials in Urologic Cancers: Could Your Patient Benefit? Maybe one of your patients could benefit from late-phase clinical trials that are currently recruiting patients with nonprostate urologic cancers.
  Medscape Medical News, December 13, 2021
• Physicians May Be Overprescribing Immunotherapy Many cancer patients who are ineligible for immunotherapy trials because of advanced disease or organ dysfunction are still receiving these drugs outside of trials, according to a new study.
  Medscape Medical News, December 08, 2021
• Novel Agent May Be Game-Changer in Rare Genetic Disease Patients with von Hippel-Lindau face a high risk of renal cell carcinoma and other cancers, which often require multiple surgeries. A new drug may change the course of the disease.
  Medscape Medical News, December 01, 2021
• Upfront Immunotherapy Combo Means Less Time on Treatment in aRCC For patients with advanced renal cell carcinoma, upfront treatment with two immune-checkpoint inhibitors provided longer treatment-free survival than sunitinib, regardless of prognostic risk group, in CheckMate 214,.
  Reuters Health Information, November 25, 2021
• Alert FDA Nod for Adjuvant Pembrolizumab in Kidney Cancer This is the first immunotherapy to be approved for adjuvant use in intermediate- or high-risk patients with renal cell carcinoma after surgery.
  FDA Approvals, November 18, 2021
• Are Oncologists Any Better at Facing Their Own Mortality? Six oncology practitioners with cancer share their stories.
  Medscape Medical News, November 03, 2021
• Cabozantinib an Option for Kidney Cancer With Brain Metastases Cabozantinib showed intracranial activity and an acceptable safety profile in a retrospective study of patients with renal cell carcinoma with brain metastases, researchers say.
  Reuters Health Information, October 29, 2021
• Convenience, Not Outcomes May Drive Robot-Assisted Surgeries Robot-assisted surgery offers the possibility of less perioperative bleeding, lower postoperative morbidity, and faster recovery times.
  Medscape Medical News, October 26, 2021
• Alert FDA Approves Cabozantinib for Differentiated Thyroid Cancer The FDA has approved cabozantinib for the treatment of advanced/metastatic differentiated thyroid cancer after disease progression.
  FDA Approvals, September 22, 2021
• To Boost Black Men in Medicine, Advocates Turn to Sports High-performing athletes possess many of the skills and attributes that physicians need, supporters of the strategy say.
  Undark, September 15, 2021
• 'Dawn of a New Era' in the Treatment of Renal Cell Carcinoma Adjuvant pembrolizumab demonstrates significant disease-free survival benefit without excess toxicity in patients at high risk of recurrence.
  Medscape Medical News, August 18, 2021
• Alert FDA OKs Belzutifan for Cancers Tied to von Hippel-Lindau Disease The new drug is for patients with von Hippel-Lindau disease who require therapy for a number of associated cancers, including renal cell carcinoma.
  FDA Approvals, August 13, 2021